Using Platelet Rich Plasma in Reducing Alveolar Bone Resorption During Rapid Maxillary Expansion - Trial NCT03028038
Access comprehensive clinical trial information for NCT03028038 through Pure Global AI's free database. This Phase 1 trial is sponsored by Damascus University and is currently Completed. The study focuses on Bone Resorption. Target enrollment is 16 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Damascus University
Timeline & Enrollment
Phase 1
Jul 01, 2016
Jul 15, 2018
Primary Outcome
Changes in buccal alveolar bone height loss and thickness reduction amount
Summary
The purpose of this study is to determine if the injection of Platelet-rich plasma (PRP) is
 effective in reducing alveolar bone loss that happens after each rapid maxillary expansion
 (RME) on the buccal aspect of the posterior teeth.
 
 16 patients with a skeletal maxillary constriction aged between 10-16 years old will get into
 orthodontic treatment to widen the maxilla using Hyrax appliance.
 
 An amount of patient blood will be withdrawn and centrifuged to get PRP. Then the PRP will be
 injected in one half of each patient mouth in a split-mouth design, beneath the buccal
 periosteal of the first molars and first premolars, the halves will be chosen randomly.
 
 High resolution CBCT images will be taken before and after orthodontic treatment to analyze
 buccal bone thickness and height changes.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT03028038
Non-Device Trial